Daniele Derudas

7PUBLICATIONS
38CO-AUTHORS
Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 27, 2025
Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. Pharmaceuticals 2025, 18, 595.

Nicola Sgherza, Olga Battisti, Paola Curci

|Apr 26, 2025
Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study.

Nicola Sgherza, Olga Battisti, Paola Curci

|Feb 13, 2025
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts.

Mattia D'Agostino, Marina Martello, Lorenzo De Paoli

|Aug 29, 2024
The Role of Monoclonal Antibodies in the Treatment of Myeloma Kidney Disease.

Daniele Derudas, Sabrina Chiriu

|May 15, 2023
Clinical Rationale of Using Steerable Technologies for Radiofrequency Ablation Followed by Cavity Creation and Cement Augmentation in the Treatment of Painful Spinal Metastases.

Claudio Pusceddu, Salvatore Marsico, Daniele Derudas

|Nov 11, 2022
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon.

Massimo Martino, Virginia Naso, Barbara Loteta

Pageof 2

Frequent Collaborators

3 joint publications

Giuseppe Mele

3 joint publications

Francesca Fazio

2 joint publications

Concetta Conticello

2 joint publications

Pellegrino Musto